CENTRAL PHARMACEUTICAL JOINT STOCK — Gliclazide Importer Profile
Pharmaceutical Importer · #6 buyer for Gliclazide · $1.8M import value · 39 shipments · VIETNAM, DEMOCRATIC REP. OF · DGFT Verified
CENTRAL PHARMACEUTICAL JOINT STOCK is the #6 importer of Gliclazide from India with $1.8M in import value and 39 verified shipments. CENTRAL PHARMACEUTICAL JOINT STOCK holds a 1.0% market share in Gliclazide imports based in VIETNAM, DEMOCRATIC REP. OF. The company sources from 1 verified supplier across 36 formulations shipped to 3 countries.
CENTRAL PHARMACEUTICAL JOINT STOCK — Gliclazide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Gliclazide to CENTRAL PHARMACEUTICAL JOINT STOCK?
Verified from 39 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $1.8M | 39 | 100.0% |
CENTRAL PHARMACEUTICAL JOINT STOCK sources Gliclazide from 1 verified Indian supplier based on 39 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
How Does CENTRAL PHARMACEUTICAL JOINT STOCK Compare to Nearest Gliclazide Importers?
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | RANBAXY FARMACEUTICA LTDA : | BRAZIL | $2.3M | 76 | $29.8K |
| 10 | FIEGE HEALTHCARE LOGISTICS GMBH | GERMANY | $2.2M | 61 | $36.2K |
| 6 | CENTRAL PHARMACEUTICAL JOINT STOCK ★ | VIETNAM | $1.6M | 33 | $50.0K |
| 12 | TORRENT DO BRASIL LIMITEDA | BRAZIL | $1.6M | 58 | $27.9K |
| 11 | SUN PHARMA CANADA INC. | CANADA | $1.4M | 27 | $50.0K |
CENTRAL PHARMACEUTICAL JOINT STOCK ranks #6 among 643 Gliclazide importers from India. Average shipment value of $50.0K compared to the market average of $40.7K. The closest competitors by value are RANBAXY FARMACEUTICA LTDA : and FIEGE HEALTHCARE LOGISTICS GMBH.
Where Does CENTRAL PHARMACEUTICAL JOINT STOCK Import Gliclazide To?
Destination countries from 39 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM, DEMOCRATIC REP. OF | $805.6K | 18 | 44.5% |
| VIETNAM | $802.8K | 17 | 44.4% |
| VIETNAM DEMOCRATIC REP. OF | $200.0K | 4 | 11.1% |
CENTRAL PHARMACEUTICAL JOINT STOCK imports Gliclazide to 3 countries. The primary destination is VIETNAM, DEMOCRATIC REP. OF receiving 44.5% of shipments worth $805.6K.
What Gliclazide Formulations Does CENTRAL PHARMACEUTICAL JOINT STOCK Import?
| Formulation | Value | Shipments |
|---|---|---|
| MELANOV - M (GLICLAZIDE 80MG + METFORMINHCL 500MG TABLETS) (10X10S) - TAX INVOICE NO: 701208303 DT: 12.01.2024PCS | $150.0K | 3 |
| MELANOV - M ( (Gliclazide 80mg + Metform | $65.7K | 2 |
| MELANOV - M (GLICLAZIDE 80MG + METFORMIN | $50.0K | 1 |
| MELANOV -M GLICLAZIDE 80MG+ METFORMIN H | $50.0K | 1 |
| MELANOV -M GLICLAZIDE 80MG+METFORMIN HC | $50.0K | 1 |
| MELANOV-M GLICLAZIDE 80MG+METFORMIN HYDROCHLORIDE 500MG TABLETS BP 10X10'S QTY-33287TAX DOCUMENT NO: 712202633/14.09.20 | $50.0K | 1 |
| MELANOV-M GLICLAZIDE 80MG+METFORMIN HCL500MG TABLETS 10X10'S QTY-39555TAXINV NO:712202651/28.09.2023 | $50.0K | 1 |
| MELANOV - M GLICLAZIDE 80MG + METFORMINHCL 500MG TABLETS10X10'SQTY- 39732TAX DOCUMENT NO: 712202674/12.10.2023 | $50.0K | 1 |
| MELANOV - M GLICLAZIDE 80MG + METFORMINHCL 500MG TABLETS10X10'SQTY- 39641TAX DOCUMENT NO: 712202698/03.11.2023 | $50.0K | 1 |
| MELANOV - M GLICLAZIDE 80MG + METFORMINHCL 500MG TABLETS 10X10s - TAX DOCUMENT NO: 712202714 DT: 16.11.2023 | $50.0K | 1 |
CENTRAL PHARMACEUTICAL JOINT STOCK imports 36 distinct Gliclazide formulations from India. The top formulation is MELANOV - M (GLICLAZIDE 80MG + METFORMINHCL 500MG TABLETS) ( with 3 shipments worth $150.0K.
Who Are the Top Buyers of Gliclazide from India and How Much Does CENTRAL PHARMACEUTICAL JOINT STOCK Import?
India exported $26.2M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. CENTRAL PHARMACEUTICAL JOINT STOCK imports $1.8M of this total, accounting for 1.0% of India's Gliclazide exports with 39 shipments from VIETNAM, DEMOCRATIC REP. OF. This is verified from 39 customs shipment records covering 36 distinct formulations.
What Is the Average Order Value for CENTRAL PHARMACEUTICAL JOINT STOCK's Gliclazide Imports?
CENTRAL PHARMACEUTICAL JOINT STOCK's average Gliclazide order value is $46.4K per consignment, based on 39 shipments totaling $1.8M. CENTRAL PHARMACEUTICAL JOINT STOCK is based in VIETNAM, DEMOCRATIC REP. OF and ranks #6 among all Gliclazide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Gliclazide to CENTRAL PHARMACEUTICAL JOINT STOCK?
CENTRAL PHARMACEUTICAL JOINT STOCK sources Gliclazide from 1 verified Indian supplier: MICRO LABS LIMITED ($1.8M, 100.0%). This is based on 39 customs records.
How Does CENTRAL PHARMACEUTICAL JOINT STOCK Compare to Other Gliclazide Importers?
CENTRAL PHARMACEUTICAL JOINT STOCK ranks #6 among 643 Gliclazide importers from India with a 1.0% market share. The top 3 importers are TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M). CENTRAL PHARMACEUTICAL JOINT STOCK processed 39 shipments from VIETNAM, DEMOCRATIC REP. OF.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CENTRAL PHARMACEUTICAL JOINT STOCK matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CENTRAL PHARMACEUTICAL JOINT STOCK's capped import value divided by total capped export value for Gliclazide across all Indian exporters.
- 5.Verified Records: This page is backed by 39 individual customs records matching CENTRAL PHARMACEUTICAL JOINT STOCK importing Gliclazide, covering 36 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gliclazide Import Data for CENTRAL PHARMACEUTICAL JOINT STOCK
Access order-level details, pricing data, supplier connections, and competitive analysis for CENTRAL PHARMACEUTICAL JOINT STOCK's Gliclazide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CENTRAL PHARMACEUTICAL JOINT STOCK
Company Profile
Multiple products · $0 total trade · Multiple categories
CENTRAL PHARMACEUTICAL JOINT STOCK × Gliclazide
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CENTRAL PHARMACEUTICAL JOINT STOCK.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current order-level data, contact TransData Nexus.